TerrAscend (TRSSF) Stock Price, News & Analysis

Company Overview

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey. In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands. It serves medical and legal adult-use markets. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

Key Stats

• Today's Range: $0.57 to $0.70
• 50-Day Range: $0.55 to $1.27
• 52-Week Range: $1.62 to $1.80
• Volume: 375,830 shs
• Average Volume: 131,026 shs
• Market Capitalization: $165.22 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TRSSF Stock Analysis - Frequently Asked Questions

How have TRSSF shares performed this year?

TerrAscend's stock was trading at $1.63 on January 1st, 2024. Since then, TRSSF stock has decreased by 57.8% and is now trading at $0.6875.
View the best growth stocks for 2024 here.

How were TerrAscend's earnings last quarter?

TerrAscend Corp. (OTCMKTS:TRSSF) released its earnings results on Tuesday, November, 16th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.29. TerrAscend had a negative net margin of 125.03% and a negative trailing twelve-month return on equity of 6.66%.

How do I buy shares of TerrAscend?

Shares of TRSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 11/16/2021
• Today: 12/19/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Agricultural production - crops
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:TRSSF
• CUSIP: N/A
• CIK: 1778129
• Web: www.terrascend.com
• Phone: (855) 837-7295
• Fax: N/A
• Employees: 740
• Year Founded: 2017

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-329,910,000.00
• Net Margins: -125.03%
• Pretax Margin: -114.03%
• Return on Equity: -6.66%
• Return on Assets: -3.07%

Debt

• Debt-to-Equity Ratio: 0.55
• Current Ratio: 0.73
• Quick Ratio: 0.40

Sales & Book Value

• Annual Sales: $247.83 million
• Price / Sales: 0.70
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.28 per share
• Price / Book: 0.54

Miscellaneous

• Outstanding Shares: 251,860,000
• Free Float: 168,925,000
• Market Cap: $173.15 million
• Optionable: Not Optionable
• Beta: 2.89